APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Biologics Regulatory Affairs Outsourcing

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Biologics Regulatory Affairs Outsourcing Industry Growth and Trends Forecast to 2032

Report ID 174079190115 April 2026110 pages

Choose your research edition.

Industry ResearchBiologics Regulatory Affairs Outsourcing Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Biologics Regulatory Affairs Outsourcing Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Biologics Regulatory Affairs Outsourcing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biologics Regulatory Affairs Outsourcing Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Biologics Regulatory Affairs Outsourcing Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

According to APO Research, the global Biologics Regulatory Affairs Outsourcing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Biologics Regulatory Affairs Outsourcing is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Biologics Regulatory Affairs Outsourcing is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biologics Regulatory Affairs Outsourcing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Biologics Regulatory Affairs Outsourcing market include Lonza AG, Wuxi AppTec Inc., Thermo Fisher Scientific Inc., Eurofins Scientific SE, Freyr solutions, Catalent Inc., Piramal Group, AGC Biologics and ICON Plc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Biologics Regulatory Affairs Outsourcing market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Biologics Regulatory Affairs Outsourcing market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Biologics Regulatory Affairs Outsourcing market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Biologics Regulatory Affairs Outsourcing.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Biologics Regulatory Affairs Outsourcing market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Biologics Regulatory Affairs Outsourcing Market by Company

Lonza AG

Wuxi AppTec Inc.

Thermo Fisher Scientific Inc.

Eurofins Scientific SE

Freyr solutions

Catalent Inc.

Piramal Group

AGC Biologics

ICON Plc.

Charles River Laboratories International, Inc.

Labcorp

Parexel International

Medpace Holdings, Inc.

IQVIA

Syneos Health

SGS SA (SGS)

Biologics Regulatory Affairs Outsourcing Segment by Type

Regulatory Consulting

Legal Representation

Regulatory Writing & Publishing

Product Registration

Regulatory Submissions

Regulatory Operations

Others

Biologics Regulatory Affairs Outsourcing Segment by Application

Monoclonal Antibodies (mAbs)

Recombinant Proteins

Vaccines

Cell & Gene Therapies

Biosimilars

Others

Biologics Regulatory Affairs Outsourcing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biologics Regulatory Affairs Outsourcing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biologics Regulatory Affairs Outsourcing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biologics Regulatory Affairs Outsourcing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Biologics Regulatory Affairs Outsourcing companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Biologics Regulatory Affairs Outsourcing Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Biologics Regulatory Affairs Outsourcing Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Biologics Regulatory Affairs Outsourcing Market Share by Region (2021-2026) Table 4. Global Biologics Regulatory Affairs Outsourcing Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Biologics Regulatory Affairs Outsourcing Market Share by Region (2027-2032) Table 6. Global Biologics Regulatory Affairs Outsourcing Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Biologics Regulatory Affairs Outsourcing Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Biologics Regulatory Affairs Outsourcing Market Size Share by Type (2021-2026) Table 9. Global Biologics Regulatory Affairs Outsourcing Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Biologics Regulatory Affairs Outsourcing Market Size Share Forecasted by Type (2027-2032) Table 11. North America Biologics Regulatory Affairs Outsourcing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Biologics Regulatory Affairs Outsourcing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Biologics Regulatory Affairs Outsourcing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Biologics Regulatory Affairs Outsourcing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Biologics Regulatory Affairs Outsourcing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Biologics Regulatory Affairs Outsourcing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Biologics Regulatory Affairs Outsourcing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Biologics Regulatory Affairs Outsourcing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Biologics Regulatory Affairs Outsourcing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Biologics Regulatory Affairs Outsourcing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Biologics Regulatory Affairs Outsourcing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Biologics Regulatory Affairs Outsourcing Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Biologics Regulatory Affairs Outsourcing Market Size Share by Application (2021-2026) Table 24. Global Biologics Regulatory Affairs Outsourcing Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Biologics Regulatory Affairs Outsourcing Market Size Share Forecasted by Application (2027-2032) Table 26. North America Biologics Regulatory Affairs Outsourcing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Biologics Regulatory Affairs Outsourcing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Biologics Regulatory Affairs Outsourcing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Biologics Regulatory Affairs Outsourcing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Biologics Regulatory Affairs Outsourcing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Biologics Regulatory Affairs Outsourcing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Biologics Regulatory Affairs Outsourcing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Biologics Regulatory Affairs Outsourcing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Biologics Regulatory Affairs Outsourcing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Biologics Regulatory Affairs Outsourcing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Biologics Regulatory Affairs Outsourcing Industry Trends Table 37. Biologics Regulatory Affairs Outsourcing Industry Drivers Table 38. Biologics Regulatory Affairs Outsourcing Industry Opportunities and Challenges Table 39. Biologics Regulatory Affairs Outsourcing Industry Restraints Table 40. Global Biologics Regulatory Affairs Outsourcing Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Biologics Regulatory Affairs Outsourcing Revenue Market Share by Company (2021-2026) Table 42. Global Biologics Regulatory Affairs Outsourcing Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Biologics Regulatory Affairs Outsourcing Key Company Headquarters & Area Served Table 44. Global Biologics Regulatory Affairs Outsourcing Company, Product Type & Application Table 45. Global Biologics Regulatory Affairs Outsourcing Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Biologics Regulatory Affairs Outsourcing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Lonza AG Company Information Table 49. Lonza AG Business Overview Table 50. Lonza AG Biologics Regulatory Affairs Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Lonza AG Biologics Regulatory Affairs Outsourcing Product Portfolio Table 52. Lonza AG Recent Development Table 53. Wuxi AppTec Inc. Company Information Table 54. Wuxi AppTec Inc. Business Overview Table 55. Wuxi AppTec Inc. Biologics Regulatory Affairs Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Wuxi AppTec Inc. Biologics Regulatory Affairs Outsourcing Product Portfolio Table 57. Wuxi AppTec Inc. Recent Development Table 58. Thermo Fisher Scientific Inc. Company Information Table 59. Thermo Fisher Scientific Inc. Business Overview Table 60. Thermo Fisher Scientific Inc. Biologics Regulatory Affairs Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Thermo Fisher Scientific Inc. Biologics Regulatory Affairs Outsourcing Product Portfolio Table 62. Thermo Fisher Scientific Inc. Recent Development Table 63. Eurofins Scientific SE Company Information Table 64. Eurofins Scientific SE Business Overview Table 65. Eurofins Scientific SE Biologics Regulatory Affairs Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Eurofins Scientific SE Biologics Regulatory Affairs Outsourcing Product Portfolio Table 67. Eurofins Scientific SE Recent Development Table 68. Freyr solutions Company Information Table 69. Freyr solutions Business Overview Table 70. Freyr solutions Biologics Regulatory Affairs Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Freyr solutions Biologics Regulatory Affairs Outsourcing Product Portfolio Table 72. Freyr solutions Recent Development Table 73. Catalent Inc. Company Information Table 74. Catalent Inc. Business Overview Table 75. Catalent Inc. Biologics Regulatory Affairs Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Catalent Inc. Biologics Regulatory Affairs Outsourcing Product Portfolio Table 77. Catalent Inc. Recent Development Table 78. Piramal Group Company Information Table 79. Piramal Group Business Overview Table 80. Piramal Group Biologics Regulatory Affairs Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Piramal Group Biologics Regulatory Affairs Outsourcing Product Portfolio Table 82. Piramal Group Recent Development Table 83. AGC Biologics Company Information Table 84. AGC Biologics Business Overview Table 85. AGC Biologics Biologics Regulatory Affairs Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. AGC Biologics Biologics Regulatory Affairs Outsourcing Product Portfolio Table 87. AGC Biologics Recent Development Table 88. ICON Plc. Company Information Table 89. ICON Plc. Business Overview Table 90. ICON Plc. Biologics Regulatory Affairs Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. ICON Plc. Biologics Regulatory Affairs Outsourcing Product Portfolio Table 92. ICON Plc. Recent Development Table 93. Charles River Laboratories International, Inc. Company Information Table 94. Charles River Laboratories International, Inc. Business Overview Table 95. Charles River Laboratories International, Inc. Biologics Regulatory Affairs Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Charles River Laboratories International, Inc. Biologics Regulatory Affairs Outsourcing Product Portfolio Table 97. Charles River Laboratories International, Inc. Recent Development Table 98. Labcorp Company Information Table 99. Labcorp Business Overview Table 100. Labcorp Biologics Regulatory Affairs Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Labcorp Biologics Regulatory Affairs Outsourcing Product Portfolio Table 102. Labcorp Recent Development Table 103. Parexel International Company Information Table 104. Parexel International Business Overview Table 105. Parexel International Biologics Regulatory Affairs Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Parexel International Biologics Regulatory Affairs Outsourcing Product Portfolio Table 107. Parexel International Recent Development Table 108. Medpace Holdings, Inc. Company Information Table 109. Medpace Holdings, Inc. Business Overview Table 110. Medpace Holdings, Inc. Biologics Regulatory Affairs Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Medpace Holdings, Inc. Biologics Regulatory Affairs Outsourcing Product Portfolio Table 112. Medpace Holdings, Inc. Recent Development Table 113. IQVIA Company Information Table 114. IQVIA Business Overview Table 115. IQVIA Biologics Regulatory Affairs Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. IQVIA Biologics Regulatory Affairs Outsourcing Product Portfolio Table 117. IQVIA Recent Development Table 118. Syneos Health Company Information Table 119. Syneos Health Business Overview Table 120. Syneos Health Biologics Regulatory Affairs Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Syneos Health Biologics Regulatory Affairs Outsourcing Product Portfolio Table 122. Syneos Health Recent Development Table 123. SGS SA (SGS) Company Information Table 124. SGS SA (SGS) Business Overview Table 125. SGS SA (SGS) Biologics Regulatory Affairs Outsourcing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. SGS SA (SGS) Biologics Regulatory Affairs Outsourcing Product Portfolio Table 127. SGS SA (SGS) Recent Development Table 128. North America Biologics Regulatory Affairs Outsourcing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Biologics Regulatory Affairs Outsourcing Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Biologics Regulatory Affairs Outsourcing Market Share by Country (2021-2026) Table 131. North America Biologics Regulatory Affairs Outsourcing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Biologics Regulatory Affairs Outsourcing Market Share Forecast by Country (2027-2032) Table 133. Europe Biologics Regulatory Affairs Outsourcing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Biologics Regulatory Affairs Outsourcing Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Biologics Regulatory Affairs Outsourcing Market Share by Country (2021-2026) Table 136. Europe Biologics Regulatory Affairs Outsourcing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Biologics Regulatory Affairs Outsourcing Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Biologics Regulatory Affairs Outsourcing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Biologics Regulatory Affairs Outsourcing Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific Biologics Regulatory Affairs Outsourcing Market Share by Country (2021-2026) Table 141. Asia-Pacific Biologics Regulatory Affairs Outsourcing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific Biologics Regulatory Affairs Outsourcing Market Share Forecast by Country (2027-2032) Table 143. Latin America Biologics Regulatory Affairs Outsourcing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America Biologics Regulatory Affairs Outsourcing Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America Biologics Regulatory Affairs Outsourcing Market Share by Country (2021-2026) Table 146. Latin America Biologics Regulatory Affairs Outsourcing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America Biologics Regulatory Affairs Outsourcing Market Share Forecast by Country (2027-2032) Table 148. Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Share by Country (2021-2026) Table 151. Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Share Forecast by Country (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Biologics Regulatory Affairs Outsourcing Product Image Figure 3. Global Biologics Regulatory Affairs Outsourcing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Biologics Regulatory Affairs Outsourcing Market Size (2021-2032) & (US$ Million) Figure 5. Global Biologics Regulatory Affairs Outsourcing Market Share by Region: 2025 VS 2032 Figure 6. Global Biologics Regulatory Affairs Outsourcing Market Share by Region (2021-2032) Figure 7. North America Biologics Regulatory Affairs Outsourcing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Biologics Regulatory Affairs Outsourcing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Biologics Regulatory Affairs Outsourcing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Biologics Regulatory Affairs Outsourcing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Regulatory Consulting Image Figure 13. Global Regulatory Consulting Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Legal Representation Image Figure 15. Global Legal Representation Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Regulatory Writing & Publishing Image Figure 17. Global Regulatory Writing & Publishing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Product Registration Image Figure 19. Global Product Registration Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Regulatory Submissions Image Figure 21. Global Regulatory Submissions Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Regulatory Operations Image Figure 23. Global Regulatory Operations Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Others Image Figure 25. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Global Biologics Regulatory Affairs Outsourcing Market Size Overview by Type (2021-2032) & (US$ Million) Figure 27. Global Biologics Regulatory Affairs Outsourcing Market Share by Type 2025 VS 2032 Figure 28. North America Biologics Regulatory Affairs Outsourcing Market Size Share by Type (2021-2032) Figure 29. Europe Biologics Regulatory Affairs Outsourcing Market Size Share by Type (2021-2032) Figure 30. Asia-Pacific Biologics Regulatory Affairs Outsourcing Market Size Share by Type (2021-2032) Figure 31. Latin America Biologics Regulatory Affairs Outsourcing Market Size Share by Type (2021-2032) Figure 32. Middle East and Africa Biologics Regulatory Affairs Outsourcing Market Size Share by Type (2021-2032) Figure 33. Monoclonal Antibodies (mAbs) Image Figure 34. Global Monoclonal Antibodies (mAbs) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Recombinant Proteins Image Figure 36. Global Recombinant Proteins Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Vaccines Image Figure 38. Global Vaccines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Cell & Gene Therapies Image Figure 40. Global Cell & Gene Therapies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Biosimilars Image Figure 42. Global Biosimilars Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. Others Image Figure 44. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. Global Biologics Regulatory Affairs Outsourcing Market Size Overview by Application (2021-2032) & (US$ Million) Figure 46. Global Biologics Regulatory Affairs Outsourcing Market Share by Application 2025 VS 2032 Figure 47. North America Biologics Regulatory Affairs Outsourcing Market Size Share by Application (2021-2032) Figure 48. Europe Biologics Regulatory Affairs Outsourcing Market Size Share by Application (2021-2032) Figure 49. Asia-Pacific Biologics Regulatory Affairs Outsourcing Market Size Share by Application (2021-2032) Figure 50. Latin America Biologics Regulatory Affairs Outsourcing Market Size Share by Application (2021-2032) Figure 51. Middle East and Africa Biologics Regulatory Affairs Outsourcing Market Size Share by Application (2021-2032) Figure 52. Global Top 5 and 10 Biologics Regulatory Affairs Outsourcing Players Market Share by Revenue in 2025 Figure 53. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 54. North America Biologics Regulatory Affairs Outsourcing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. North America Biologics Regulatory Affairs Outsourcing Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. North America Biologics Regulatory Affairs Outsourcing Market Share by Country (2021-2032) Figure 57. Europe Biologics Regulatory Affairs Outsourcing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Biologics Regulatory Affairs Outsourcing Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Biologics Regulatory Affairs Outsourcing Market Share by Country (2021-2032) Figure 60. Asia-Pacific Biologics Regulatory Affairs Outsourcing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Asia-Pacific Biologics Regulatory Affairs Outsourcing Market Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Biologics Regulatory Affairs Outsourcing Market Share by Country (2021-2032) Figure 63. Latin America Biologics Regulatory Affairs Outsourcing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Biologics Regulatory Affairs Outsourcing Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Biologics Regulatory Affairs Outsourcing Market Share by Country (2021-2032) Figure 66. Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 67. Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Share by Country: 2021 VS 2025 VS 2032 Figure 68. Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Share by Country (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Regulatory Consulting
  • Legal Representation
  • Regulatory Writing & Publishing
  • Product Registration
  • Regulatory Submissions
  • Regulatory Operations
  • Others
Applications
  • Monoclonal Antibodies (mAbs)
  • Recombinant Proteins
  • Vaccines
  • Cell & Gene Therapies
  • Biosimilars
  • Others
Companies covered
  • Lonza AG
  • Wuxi AppTec Inc.
  • Thermo Fisher Scientific Inc.
  • Eurofins Scientific SE
  • Freyr solutions
  • Catalent Inc.
  • Piramal Group
  • AGC Biologics
  • ICON Plc.
  • Charles River Laboratories International, Inc.
  • Labcorp
  • Parexel International
  • Medpace Holdings, Inc.
  • IQVIA
  • Syneos Health
  • SGS SA (SGS)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Biologics Regulatory Affairs Outsourcing Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Biologics Regulatory Affairs Outsourcing Market Size by Region (2021-2032)
  5. 1.4.1 Global Biologics Regulatory Affairs Outsourcing Market Size by Region (2021-2026)
  6. 1.4.2 Global Biologics Regulatory Affairs Outsourcing Market Size by Region (2027-2032)
  7. 1.5 Key Regions Biologics Regulatory Affairs Outsourcing Market Size (2021-2032)
  8. 1.5.1 North America Biologics Regulatory Affairs Outsourcing Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Biologics Regulatory Affairs Outsourcing Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Biologics Regulatory Affairs Outsourcing Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Biologics Regulatory Affairs Outsourcing Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Size Growth Rate (2021-2032)
2 Biologics Regulatory Affairs Outsourcing Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Regulatory Consulting
  3. 2.1.2 Legal Representation
  4. 2.1.3 Regulatory Writing & Publishing
  5. 2.1.4 Product Registration
  6. 2.1.5 Regulatory Submissions
  7. 2.1.6 Regulatory Operations
  8. 2.1.7 Others
  9. 2.2 Global Biologics Regulatory Affairs Outsourcing Market Size by Type
  10. 2.2.1 Global Biologics Regulatory Affairs Outsourcing Market Size Overview by Type (2021-2032)
  11. 2.2.2 Global Biologics Regulatory Affairs Outsourcing Historic Market Size Review by Type (2021-2026)
  12. 2.2.3 Global Biologics Regulatory Affairs Outsourcing Market Size Forecasted by Type (2027-2032)
  13. 2.3 Global Biologics Regulatory Affairs Outsourcing Market Size by Regions
  14. 2.3.1 North America Biologics Regulatory Affairs Outsourcing Market Size Breakdown by Type (2021-2026)
  15. 2.3.2 Europe Biologics Regulatory Affairs Outsourcing Market Size Breakdown by Type (2021-2026)
  16. 2.3.3 Asia-Pacific Biologics Regulatory Affairs Outsourcing Market Size Breakdown by Type (2021-2026)
  17. 2.3.4 South America Biologics Regulatory Affairs Outsourcing Market Size Breakdown by Type (2021-2026)
  18. 2.3.5 Middle East and Africa Biologics Regulatory Affairs Outsourcing Market Size Breakdown by Type (2021-2026)
3 Biologics Regulatory Affairs Outsourcing Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Monoclonal Antibodies (mAbs)
  3. 3.1.2 Recombinant Proteins
  4. 3.1.3 Vaccines
  5. 3.1.4 Cell & Gene Therapies
  6. 3.1.5 Biosimilars
  7. 3.1.6 Others
  8. 3.2 Global Biologics Regulatory Affairs Outsourcing Market Size by Application
  9. 3.2.1 Global Biologics Regulatory Affairs Outsourcing Market Size Overview by Application (2021-2032)
  10. 3.2.2 Global Biologics Regulatory Affairs Outsourcing Historic Market Size Review by Application (2021-2026)
  11. 3.2.3 Global Biologics Regulatory Affairs Outsourcing Market Size Forecasted by Application (2027-2032)
  12. 3.3 Global Biologics Regulatory Affairs Outsourcing Market Size by Regions
  13. 3.3.1 North America Biologics Regulatory Affairs Outsourcing Market Size Breakdown by Application (2021-2026)
  14. 3.3.2 Europe Biologics Regulatory Affairs Outsourcing Market Size Breakdown by Application (2021-2026)
  15. 3.3.3 Asia-Pacific Biologics Regulatory Affairs Outsourcing Market Size Breakdown by Application (2021-2026)
  16. 3.3.4 South America Biologics Regulatory Affairs Outsourcing Market Size Breakdown by Application (2021-2026)
  17. 3.3.5 Middle East and Africa Biologics Regulatory Affairs Outsourcing Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Biologics Regulatory Affairs Outsourcing Industry Trends
  2. 4.2 Biologics Regulatory Affairs Outsourcing Industry Drivers
  3. 4.3 Biologics Regulatory Affairs Outsourcing Industry Opportunities and Challenges
  4. 4.4 Biologics Regulatory Affairs Outsourcing Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Biologics Regulatory Affairs Outsourcing Revenue (2021-2026)
  2. 5.2 Global Biologics Regulatory Affairs Outsourcing Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Biologics Regulatory Affairs Outsourcing Key Company Headquarters & Area Served
  4. 5.4 Global Biologics Regulatory Affairs Outsourcing Company, Product Type & Application
  5. 5.5 Global Biologics Regulatory Affairs Outsourcing Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Biologics Regulatory Affairs Outsourcing Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Biologics Regulatory Affairs Outsourcing Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Biologics Regulatory Affairs Outsourcing Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Lonza AG
  2. 6.1.1 Lonza AG Company Information
  3. 6.1.2 Lonza AG Business Overview
  4. 6.1.3 Lonza AG Biologics Regulatory Affairs Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Lonza AG Biologics Regulatory Affairs Outsourcing Product Portfolio
  6. 6.1.5 Lonza AG Recent Developments
  7. 6.2 Wuxi AppTec Inc.
  8. 6.2.1 Wuxi AppTec Inc. Company Information
  9. 6.2.2 Wuxi AppTec Inc. Business Overview
  10. 6.2.3 Wuxi AppTec Inc. Biologics Regulatory Affairs Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Wuxi AppTec Inc. Biologics Regulatory Affairs Outsourcing Product Portfolio
  12. 6.2.5 Wuxi AppTec Inc. Recent Developments
  13. 6.3 Thermo Fisher Scientific Inc.
  14. 6.3.1 Thermo Fisher Scientific Inc. Company Information
  15. 6.3.2 Thermo Fisher Scientific Inc. Business Overview
  16. 6.3.3 Thermo Fisher Scientific Inc. Biologics Regulatory Affairs Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Thermo Fisher Scientific Inc. Biologics Regulatory Affairs Outsourcing Product Portfolio
  18. 6.3.5 Thermo Fisher Scientific Inc. Recent Developments
  19. 6.4 Eurofins Scientific SE
  20. 6.4.1 Eurofins Scientific SE Company Information
  21. 6.4.2 Eurofins Scientific SE Business Overview
  22. 6.4.3 Eurofins Scientific SE Biologics Regulatory Affairs Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Eurofins Scientific SE Biologics Regulatory Affairs Outsourcing Product Portfolio
  24. 6.4.5 Eurofins Scientific SE Recent Developments
  25. 6.5 Freyr solutions
  26. 6.5.1 Freyr solutions Company Information
  27. 6.5.2 Freyr solutions Business Overview
  28. 6.5.3 Freyr solutions Biologics Regulatory Affairs Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Freyr solutions Biologics Regulatory Affairs Outsourcing Product Portfolio
  30. 6.5.5 Freyr solutions Recent Developments
  31. 6.6 Catalent Inc.
  32. 6.6.1 Catalent Inc. Company Information
  33. 6.6.2 Catalent Inc. Business Overview
  34. 6.6.3 Catalent Inc. Biologics Regulatory Affairs Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Catalent Inc. Biologics Regulatory Affairs Outsourcing Product Portfolio
  36. 6.6.5 Catalent Inc. Recent Developments
  37. 6.7 Piramal Group
  38. 6.7.1 Piramal Group Company Information
  39. 6.7.2 Piramal Group Business Overview
  40. 6.7.3 Piramal Group Biologics Regulatory Affairs Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Piramal Group Biologics Regulatory Affairs Outsourcing Product Portfolio
  42. 6.7.5 Piramal Group Recent Developments
  43. 6.8 AGC Biologics
  44. 6.8.1 AGC Biologics Company Information
  45. 6.8.2 AGC Biologics Business Overview
  46. 6.8.3 AGC Biologics Biologics Regulatory Affairs Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 AGC Biologics Biologics Regulatory Affairs Outsourcing Product Portfolio
  48. 6.8.5 AGC Biologics Recent Developments
  49. 6.9 ICON Plc.
  50. 6.9.1 ICON Plc. Company Information
  51. 6.9.2 ICON Plc. Business Overview
  52. 6.9.3 ICON Plc. Biologics Regulatory Affairs Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 ICON Plc. Biologics Regulatory Affairs Outsourcing Product Portfolio
  54. 6.9.5 ICON Plc. Recent Developments
  55. 6.10 Charles River Laboratories International, Inc.
  56. 6.10.1 Charles River Laboratories International, Inc. Company Information
  57. 6.10.2 Charles River Laboratories International, Inc. Business Overview
  58. 6.10.3 Charles River Laboratories International, Inc. Biologics Regulatory Affairs Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Charles River Laboratories International, Inc. Biologics Regulatory Affairs Outsourcing Product Portfolio
  60. 6.10.5 Charles River Laboratories International, Inc. Recent Developments
  61. 6.11 Labcorp
  62. 6.11.1 Labcorp Company Information
  63. 6.11.2 Labcorp Business Overview
  64. 6.11.3 Labcorp Biologics Regulatory Affairs Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Labcorp Biologics Regulatory Affairs Outsourcing Product Portfolio
  66. 6.11.5 Labcorp Recent Developments
  67. 6.12 Parexel International
  68. 6.12.1 Parexel International Company Information
  69. 6.12.2 Parexel International Business Overview
  70. 6.12.3 Parexel International Biologics Regulatory Affairs Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Parexel International Biologics Regulatory Affairs Outsourcing Product Portfolio
  72. 6.12.5 Parexel International Recent Developments
  73. 6.13 Medpace Holdings, Inc.
  74. 6.13.1 Medpace Holdings, Inc. Company Information
  75. 6.13.2 Medpace Holdings, Inc. Business Overview
  76. 6.13.3 Medpace Holdings, Inc. Biologics Regulatory Affairs Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Medpace Holdings, Inc. Biologics Regulatory Affairs Outsourcing Product Portfolio
  78. 6.13.5 Medpace Holdings, Inc. Recent Developments
  79. 6.14 IQVIA
  80. 6.14.1 IQVIA Company Information
  81. 6.14.2 IQVIA Business Overview
  82. 6.14.3 IQVIA Biologics Regulatory Affairs Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 IQVIA Biologics Regulatory Affairs Outsourcing Product Portfolio
  84. 6.14.5 IQVIA Recent Developments
  85. 6.15 Syneos Health
  86. 6.15.1 Syneos Health Company Information
  87. 6.15.2 Syneos Health Business Overview
  88. 6.15.3 Syneos Health Biologics Regulatory Affairs Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Syneos Health Biologics Regulatory Affairs Outsourcing Product Portfolio
  90. 6.15.5 Syneos Health Recent Developments
  91. 6.16 SGS SA (SGS)
  92. 6.16.1 SGS SA (SGS) Company Information
  93. 6.16.2 SGS SA (SGS) Business Overview
  94. 6.16.3 SGS SA (SGS) Biologics Regulatory Affairs Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 SGS SA (SGS) Biologics Regulatory Affairs Outsourcing Product Portfolio
  96. 6.16.5 SGS SA (SGS) Recent Developments
7 North America
  1. 7.1 North America Biologics Regulatory Affairs Outsourcing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Biologics Regulatory Affairs Outsourcing Market Size by Country (2021-2026)
  3. 7.3 North America Biologics Regulatory Affairs Outsourcing Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Biologics Regulatory Affairs Outsourcing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Biologics Regulatory Affairs Outsourcing Market Size by Country (2021-2026)
  3. 8.3 Europe Biologics Regulatory Affairs Outsourcing Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Biologics Regulatory Affairs Outsourcing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Biologics Regulatory Affairs Outsourcing Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Biologics Regulatory Affairs Outsourcing Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Biologics Regulatory Affairs Outsourcing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Biologics Regulatory Affairs Outsourcing Market Size by Country (2021-2026)
  3. 10.3 South America Biologics Regulatory Affairs Outsourcing Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst